Biogen (BIIB) Misses Q1 EPS by 6c; Revs Light

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to Biogen (BIIB) Misses Q1 EPS by 6c; Revs Light

Biogen Reports First Quarter 2015 Revenues of $2.6 Billion

April 24, 2015 7:00 AM EDT

Multiple sclerosis portfolio gains share globally with ongoing TECFIDERA® rollout in Europe and launch of PLEGRIDY®

Company advances research pipeline and development efforts in Alzheimers disease, secondary progressive MS and neurological repair for MS

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) today reported first quarter 2015 results, including revenues of $2.6 billion, a 20% increase compared to the first quarter of 2014. Non-GAAP diluted earnings per share (EPS) for the first quarter of 2015 were $3.82, an increase of 55% over the first quarter of 2014.... More